Phase 3 Trial of Recombinant Human Alkaline Phosphatase for Patients with Sepsis-Associated Acute Kidney Injury (REVIVAL)
Peter Pickkers(Radboud University Nijmegen), Alexander Zarbock(University Hospital Münster), Rinaldo Bellomo(The University of Melbourne), Ville Pettilä(University of Helsinki), Henrik Gammelager(Aarhus University Hospital), John A. Kellum(University of Pittsburgh), Kent Doi(University of Tokyo Hospital), Michael Joannidis(Innsbruck Medical University), Ricard Ferrer(Universitat Autònoma de Barcelona), Paul J. Young(Wellington Hospital), Alistair Nichol(University College Dublin), Christopher J. Doig(Alberta Health Services), Morten H. Bestle(University of Copenhagen), Juliane Bernholz(AM–Pharma (Netherlands)), Kathleen D. Liu(University of California San Francisco Medical Center), Marlies Ostermann(St Thomas' Hospital), Scott J. Millington(University of Ottawa), Eric A. J. Hoste(Ghent University Hospital), Ravindra L. Mehta(University of California San Diego), Patrick Murray(Mater Misericordiae University Hospital), Ulf Goettrup(Zealand University Hospital), Melanie Meersch(University Hospital Münster), Bruno François(Inserm), Matthias Winkel(AM–Pharma (Netherlands)), Christopher Solling(Regionshospitalet Viborg), Susanne Iversen(Mahindra and Mahindra Limited (India)), Derek C. Angus(University of Pittsburgh), Kristie Bass(AM–Pharma (Netherlands)), Erik van den Berg(AM–Pharma (Netherlands))
Cited by 8
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
|Critical Care|2007|7.1k